2 01/11/2024 31/10/2025 2025-10-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-11-01 Sage Accounts Production 25.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 11626731 2024-11-01 2025-10-31 11626731 2025-10-31 11626731 2024-10-31 11626731 2023-11-01 2024-10-31 11626731 2024-10-31 11626731 2023-10-31 11626731 bus:RegisteredOffice 2024-11-01 2025-10-31 11626731 bus:LeadAgentIfApplicable 2024-11-01 2025-10-31 11626731 bus:Director1 2024-11-01 2025-10-31 11626731 bus:Director2 2024-11-01 2025-10-31 11626731 core:WithinOneYear 2025-10-31 11626731 core:WithinOneYear 2024-10-31 11626731 bus:Micro-entities 2024-11-01 2025-10-31 11626731 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 11626731 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 11626731 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11626731 bus:FullAccounts 2024-11-01 2025-10-31
Company registration number: 11626731
(England and Wales)
Marlow Neurodevelopment Ltd
Unaudited filleted financial statements
for the year ended
31 October 2025
Marlow Neurodevelopment Ltd
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Marlow Neurodevelopment Ltd
Directors and other information

| Directors | Dr Benjamin Marlow
|  | Dr Stephanie Marlow
| Company number | 11626731
| Registered office | Tye House, Elmstead Road
|  | Elmstead
|  | Colchester
|  | Essex
|  | CO7 7AX
| Accountants | Griffin Chapman
|  | 4 & 5 The Cedars, Apex 12
|  | Old Ipswich Road
|  | Colchester
|  | Essex
|  | CO7 7QR

Marlow Neurodevelopment Ltd
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of Marlow Neurodevelopment Ltd
Year ended 31 October 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Marlow Neurodevelopment Ltd for the year ended 31 October 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of Marlow Neurodevelopment Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Marlow Neurodevelopment Ltd and state those matters that we have agreed to state to the board of directors of Marlow Neurodevelopment Ltd as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Marlow Neurodevelopment Ltd and its board of directors as a body for our work or for this report.
It is your duty to ensure that Marlow Neurodevelopment Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Marlow Neurodevelopment Ltd. You consider that Marlow Neurodevelopment Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Marlow Neurodevelopment Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Griffin Chapman
Chartered Accountants
4 & 5 The Cedars, Apex 12
Old Ipswich Road
Colchester
Essex
CO7 7QR
19 March 2026
Marlow Neurodevelopment Ltd
Statement of financial position
31 October 2025

|  |  | 2025 |  |  | 2024 |
|  |  | £ | £ |  | £ | £
Fixed assets |  |  |  | 2,904 |  |  | 938
|  |  |  | _______ |  |  | _______
Current assets |  |  | 63,409 |  |  | 45,019 |
Prepayments and accrued income |  |  | 2,692 |  |  | 2,777 |
|  |  | _______ |  |  | _______ |
|  |  |  | 66,101 |  |  | 47,796
Creditors: amounts falling due within one year |  |  |  | ( 7,233) |  |  | ( 12,268)
|  |  |  | _______ |  |  | _______
Net current assets |  |  |  | 58,868 |  |  | 35,528
|  |  |  | _______ |  |  | _______
Total assets less current liabilities |  |  |  | 61,772 |  |  | 36,466
Accruals and deferred income |  |  |  | ( 1,419) |  |  | ( 1,411)
|  |  |  | _______ |  |  | _______
Net assets |  |  |  | 60,353 |  |  | 35,055
|  |  |  | _______ |  |  | _______
Capital and reserves |  |  |  | 60,353 |  |  | 35,055
|  |  |  | _______ |  |  | _______

Notes to the financial statements
Marlow Neurodevelopment Ltd
Year ended 31 October 2025
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 26 February 2026 , and are signed on behalf of the board by:
Dr Benjamin Marlow
Director
Company registration number: 11626731
The company is a private company limited by shares, registered in England and Wales.